Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

DexCom completes $22.5mm Series D financing

Executive Summary

DexCom (glucose monitors) grossed $22.5mm with its Series D venture round to new investors Warburg Pincus (which led the round) and the Vertical Group. Also participating in the financing were existing backers Canaan Partners, Federated Kaufmann Fund, RWI Group, St. Paul Venture Capital, and Fog City Fund (an affiliate of St. Paul). Piper Jaffray acted as placement agent.
Deal Industry
  • In Vitro Diagnostics
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Implantable Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
    • Glucose Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies